NexImmune, Inc.: Private, clinical-stage IO company developing unique approach to antigen-specific T cell therapy. Synthetic nanoparticles decorated w a combo of multiple tumor relevant antigens and co-stimulatory signals engaging directly w targeted T cells to orchestrate specific immune responses to cancer. Product applications as both SQ injectable and adoptively transferred cellular therapy. Two Ph 1's ongoing.
Sector/industry:
Healthcare/Biotechnology
Characteristics:
Based in...
US - South Atlantic
Clinical Stage
Phase l or ll, Pre-Clinical Stage
Disease Space
Immuno-Oncology, Oncology
Industry
Biotechnology, Pharmaceuticals
Listing
Private
Therapeutic Modalities
Cell Therapy
Website:
Profiles:
Address:
9119 Gaither Road
Gaithersburg, MD 20877
United States

Company Participants at Solebury Trout Virtual Global Healthcare Conference Series

  • Scott Carmer, President & CEO

Send Message to Request Information

Log in to download presentation, request a 1x1 meeting, view additional roadshows, and more.